Literature DB >> 18636735

Isolation and characterization of immunostimulatory polysaccharide from an herb tea, Gynostemma pentaphyllum Makino.

Xingbin Yang1, Yan Zhao, Ying Yang, Yun Ruan.   

Abstract

Water-soluble polysaccharide from Gynostemma pentaphyllum herb tea (PSGP) was isolated by hot-water extraction and ethanol precipitation. The chemical components and preliminary immunomodulating activity of PSGP were investigated both in vitro and in vivo. Capillary zone electrophoresis analysis showed that PSGP was a typical nonstarch heteropolysaccharide, with glucose being the main component monosaccharide (23.2%), followed by galactose (18.9%), arabinose (10.5%), rhamnose (7.7%), galacturonic acid (4.7%), xylose (3.9%), mannose (3.1%), and glucuronic acid (1.2%). PSGP could significantly stimulate peritoneal macrophages to release nitric oxide, reactive oxygen species, and tumor necrosis factor-alpha in a dose-dependent manner. This immunostimulating activity of PSGP was further demonstrated by its inhibition on the proliferation of human colon carcinoma HT-29 and SW-116 cells incubated with the supernatant of PSGP-stimulated macrophage culture. It is evident that PSGP is a very important ingredient responsible for at least in part the immunomodulating activity of G. pentaphyllum herb tea.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18636735     DOI: 10.1021/jf801101u

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  15 in total

1.  Ability of the polysaccharide chitosan to inhibit proliferation of CD4+ lymphocytes from mucosal inductive sites, in vitro and in vivo.

Authors:  C Porporatto; M M Canali; I D Bianco; S G Correa
Journal:  Cell Prolif       Date:  2009-08-17       Impact factor: 6.831

2.  Sulfated modification and cytotoxicity of Portulaca oleracea L. polysaccharides.

Authors:  Tong Chen; Jin Wang; Yuanyuan Li; Jianmin Shen; Ting Zhao; Haixia Zhang
Journal:  Glycoconj J       Date:  2010-09-04       Impact factor: 2.916

3.  Targeting of growth factors in the treatment of hepatocellular carcinoma: The potentials of polysaccharides.

Authors:  Xuan Wang; Jieyu Ding; Yuanyuan Feng; Lingling Weng; Guangqiang Zhao; Jianfeng Xiang; Minguang Zhang; Dongwei Xing
Journal:  Oncol Lett       Date:  2017-01-17       Impact factor: 2.967

4.  Purification of a water extract of Chinese sweet tea plant (Rubus suavissimus S. Lee) by alcohol precipitation.

Authors:  Gar Yee Koh; Guixin Chou; Zhijun Liu
Journal:  J Agric Food Chem       Date:  2009-06-10       Impact factor: 5.279

5.  Ameliorating effects of gypenosides on chronic stress-induced anxiety disorders in mice.

Authors:  Ting Ting Zhao; Keon Sung Shin; Hyun Sook Choi; Myung Koo Lee
Journal:  BMC Complement Altern Med       Date:  2015-09-14       Impact factor: 3.659

6.  A polysaccharide from Dendrobium huoshanense prevents hepatic inflammatory response caused by carbon tetrachloride.

Authors:  Chang-Cheng Tian; Xue-Qiang Zha; Jian-Ping Luo
Journal:  Biotechnol Biotechnol Equip       Date:  2014-12-06       Impact factor: 1.632

Review 7.  Portulaca oleracea L.: a review of phytochemistry and pharmacological effects.

Authors:  Yan-Xi Zhou; Hai-Liang Xin; Khalid Rahman; Su-Juan Wang; Cheng Peng; Hong Zhang
Journal:  Biomed Res Int       Date:  2015-01-26       Impact factor: 3.411

Review 8.  Anti-cancer effects of Gynostemma pentaphyllum (Thunb.) Makino (Jiaogulan).

Authors:  Yantao Li; Wanjun Lin; Jiajun Huang; Ying Xie; Wenzhe Ma
Journal:  Chin Med       Date:  2016-09-27       Impact factor: 5.455

9.  Metabonomics study of the therapeutic mechanism of Gynostemma pentaphyllum and atorvastatin for hyperlipidemia in rats.

Authors:  Miao Wang; Fei Wang; Yinan Wang; Xiaonan Ma; Min Zhao; Chunjie Zhao
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

10.  In Vitro Anticancer Activity of a Nonpolar Fraction from Gynostemma pentaphyllum (Thunb.) Makino.

Authors:  Yantao Li; Jiajun Huang; Wanjun Lin; Zhongwen Yuan; Senling Feng; Ying Xie; Wenzhe Ma
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-29       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.